Renescience A/S

The financial health of Renescience A/S appears to be precarious, with significant losses reported over the past few years. In 2024, the company generated revenue of 10,836,000 DKK but incurred a substantial loss of 23,904,000 DKK, indicating ongoing profitability challenges. While revenue has shown a slight increase from 7,970,000 DKK in 2021 to 10,836,000 DKK in 2024, the profit margins remain deeply negative, raising concerns about sustainability. Equity has fluctuated dramatically, dropping from 182,960,000 DKK in 2022 to 7,407,000 DKK in 2024, suggesting a deteriorating financial position. Overall, Renescience A/S faces significant challenges in achieving profitability and stabilizing its equity amidst a competitive landscape in the research and experimental development sector.

AI-generated summary